Access To Medicine Foundation | Access to Medicine Foundation

ACCESS TO MEDICINE INDEX 2022

Featured insights

Discover the latest at the Foundation

Foundation names Expert Committee for the Generic Medicine Manufacturers Research Programme

25 November 2022

Drugmakers that dominate the world's insulin market must scale up access efforts globally

06 October 2022

Explore our research sectors

Big pharma

We influence and encourage them to make their products accessible for all.

Generic medicine manufacturers

We empower the industry to become more responsive

Medical gas companies

We stimulate the industry to ensure availability for treatments and procedures.

Antimicrobial Resistance

We motivate the industry to increase appropriate access to antimicrobials.

Diagnostic companies

We forge partnerships to unlock the potential of diagnostics.

Resource centre

Explore our research reports and publications

Featured Key findings

More access plans and strategies to expand access to more products, but with limited breadth and depth

15 November 2022

Featured Research

The Methodology for the 2022 Access to Medicine Index

22 September 2021

Lack of access to medicine is a major driver of drug resistance. How can pharma take action?

27 October 2022

How companies compare

Learn more about how pharmaceutical companies perform in Acess to Medicine Index

Events and engagements

SHARING OUR INSIGHTS TO SUPPORT CHANGE MAKING

Access to Medicine Foundation to share insights on access to medical oxygen at 2022 gasworld conference

14 December 2022

International Conference on Public Health in Africa: Building more resilient health systems

13 December 2022

Health is Wealth Summit: Anne-Charlotte Douard to speak on healthcare access in Africa

12 December 2022

MPP Strategy Launch Event: Jayasree K. Iyer to speak on the expansion of novel medical technologies

30 January 2023

Media coverage

Read more about our coverage in global media

Maintaining momentum to oxygen and enhancing supply security

15 December 2022

Access plans increasingly part of drugmakers’ strategies, says report

15 November 2022